Castle Creek Arbitrage’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,000
Closed -$7.71K 325
2023
Q2
$7.71K Hold
50,000
﹤0.01% 294
2023
Q1
$3.58K Hold
50,000
﹤0.01% 422
2022
Q4
$3K Hold
50,000
﹤0.01% 465
2022
Q3
$4K Hold
50,000
﹤0.01% 612
2022
Q2
$4K Hold
50,000
﹤0.01% 640
2022
Q1
$17K Hold
50,000
﹤0.01% 620
2021
Q4
$31K Hold
50,000
﹤0.01% 637
2021
Q3
$34K Hold
50,000
﹤0.01% 594
2021
Q2
$47K Buy
+50,000
New +$39.9K ﹤0.01% 607

Other funds holding AONCW

Castle Creek Arbitrage's AONCW Position: Q3 2023 in Review

Castle Creek Arbitrage sold out of American Oncology Network, Inc. Warrant (AONCW) in Q3 2023, closing a stake of 50,000 shares — an estimated $7.71K sold.

Castle Creek Arbitrage first reported a position in AONCW in Q2 2021 and held it in 9 quarters. The position peaked at $47K in Q2 2021. 34 funds tracked by Wall St. Rank hold AONCW as of Q3 2023.

  • Castle Creek Arbitrage reported no remaining American Oncology Network, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 50,000 American Oncology Network, Inc. Warrant shares in Q3 2023, an estimated $7.71K.
  • Castle Creek Arbitrage first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 9 quarters.
  • Castle Creek Arbitrage's American Oncology Network, Inc. Warrant position peaked at $47K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q3 2023.

Based on Castle Creek Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.